For localized information and support, would you like to switch to your country-specific website for {0}?
Key takeaways
- Part 1 : Prevention and Screening - the first 3 episodes emphasize the value of implementing biomarker-based screening and real-world evidence to improve early heart failure prevention and cardiometabolic risk assessment in both specific high-risk groups and the general population
- Part 2: Diagnosis - two episodes on diagnosis highlight the critical importance of making heart failure diagnostic tools accessible to both non-specialists and in primary care settings to enable earlier diagnosis and intervention
- Part 3: Implementation - the final two episodes of the series address the practical challenges and strategies involved in implementing new guidelines and protocols, such as STRONG-HF and the ESC rapid 0/1h algorithm, to accelerate adoption in clinical practice
Podcast series on the newest advancements in the management of cardiometabolic diseases
Welcome to the proCardio podcast series by Roche, offering an overview of advancements in the prevention, screening, diagnosis, and implementation strategies for cardiometabolic disease management
Featuring interviews with leading clinicians, the series covers critical topics including insights on cardiac biomarkers' use from real-world evidence, translating heart failure guidelines into practice, enabling early diagnosis, and discussing innovative trials.
Join the host Konstantin Schmidt, Scientific Communications Manager at Roche Diagnostics, as he engages with the brightest minds in the field to bring you 7 episodes, packed with expert insights and practical knowledge to help enhance clinical care for cardiometabolic diseases.
Prevention and Screening
Real world evidence and opportunities for early intervention in heart failure
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Real world evidence and opportunities for early intervention in heart failure for people living with diabetes
Interview with Dr. Safia Chatur on the importance of real world evidence and what it tells us about the use of biomarkers (such as natriuretic peptides) in clinical routine for heart failure identification in people living with diabetes.
Implementation of NT-proBNP based screening for heart failure prevention in people with diabetes
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Implementation of NT-proBNP based screening for heart failure prevention in people with diabetes
Interview with Dr. Rodica Pop-Busui on her extensive experience in implementing a heart failure screening program in a university network, translating guideline recommendation into clinical care.
Value of Troponins in Predicting Cardiovascular Disease Risk in the General Population
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Value of Troponins in Predicting Cardiovascular Disease Risk in the General Population
Interview with Dr. Raphael Twerenbold on cardiometabolic risk assessment in the general population. Current standard of care and its limitations are explored along with the advantages of incorporating biomarkers in existing protocols.
Diagnostics
Early diagnosis of heart failure in primary care
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Early diagnosis of heart failure in primary care
Interview with Dr. Antoni Bayes-Genis on enabling early diagnosis of heart failure, the implementation of practical algorithms using NT-proBNP in different settings, and the role point of care plays in the process.
Accessibility to heart failure diagnostic tools for non-specialists: the SYMPHONY trial
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Accessibility to heart failure diagnostic tools for non-specialists: the SYMPHONY trial
Interview with Dr. Mark Petrie focused on the SYMPHONY trial, creating evidence in support of providing non-specialists with diagnostic tools for early identification of heart failure.
Implementation
Implementation of the STRONG-HF protocol in clinical practice in the UK
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Implementation of the STRONG-HF protocol in clinical practice in the UK
Interview with Dr. Lisa Anderson, in which she provides updates on the recent implementation of the guideline-recommended STRONG-HF protocol in practice in the UK.
Barriers to implementation rapid ESC algorithms for triaging patients suspected of ACS
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Barriers to implementation rapid ESC algorithms for triaging patients suspected of ACS
Interview with Dr. Kirsten Aakre exploring some of the underlying reasons for the relatively slow uptake of the ESC 0/1h algorithm in clinical practice and discussing potential strategies to accelerate its implementation.
Explore articles from our communities
Join the CarDiaLogue community
CarDiaLogue brings you the latest valuable perspectives from some of the sharpest minds in cardiology to complement your specialist skills.
We provide access to insights from world-renown experts and thought leaders, sharing the latest clinical evidence, presenting the newest guidelines, offering educational events, and providing actionable insights for the management of cardiometabolic diseases.
Get a free copy of our latest infographic when you sign up for the CarDiaLogue community and be the first to receive updates with the latest cardiology insights.